Approach to Imaging Ischemia in Women.
Journal
Journal of thoracic imaging
ISSN: 1536-0237
Titre abrégé: J Thorac Imaging
Pays: United States
ID NLM: 8606160
Informations de publication
Date de publication:
01 Jul 2023
01 Jul 2023
Historique:
medline:
29
6
2023
pubmed:
26
5
2023
entrez:
26
5
2023
Statut:
ppublish
Résumé
Approach to imaging ischemia in women Coronary artery disease in women tends to have a worse short- and long-term prognosis relative to men and remains the leading cause of mortality worldwide. Both clinical symptoms and diagnostic approach remain challenging in women due to lesser likelihood of women presenting with classic anginal symptoms on one hand and underperformance of conventional exercise treadmill testing in women on the other. Moreover, a higher proportion of women with signs and symptoms suggestive of ischemia are more likely to have nonobstructive coronary artery disease (CAD) that requires additional imaging and therapeutic considerations. New imaging techniques such as coronary computed tomography (CT) angiography, CT myocardial perfusion imaging, CT functional flow reserve assessment, and cardiac magnetic resonance imaging carry substantially better sensitivity and specificity for the detection of ischemia and coronary artery disease in women. Familiarity with various clinical subtypes of ischemic heart disease in women and with the major advantages and disadvantages of advanced imaging tests to ensure the decision to select one modality over another is one of the keys to successful diagnosis of CAD in women. This review compares the 2 major types of ischemic heart disease in women - obstructive and nonobstructive, while focusing on sex-specific elements of its pathophysiology.
Identifiants
pubmed: 37233994
doi: 10.1097/RTI.0000000000000719
pii: 00005382-202307000-00002
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
204-211Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics—2020 update: a report from the american heart association. Circulation. 2020;141:e139–e596.
Fairbairn TA, Dobson R, Hurwitz-Koweek L, et al. Sex differences in coronary computed tomography angiography–derived fractional flow reserve. JACC: Cardiovascular Imaging. 2020;13:2576–2587.
Rodriguez Lozano PF, Rrapo Kaso E, Bourque JM, et al. Cardiovascular imaging for ischemic heart disease in women. JACC: Cardiovascular Imaging. 2022;15:1488–1501.
Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144:e368–e454.
Regitz-Zagrosek V, Oertelt-Prigione S, Prescott E, et al. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J. 2016;37:24–34.
Garcia M, Mulvagh SL, Merz CNB, et al. Cardiovascular disease in women: clinical perspectives. Circ Res. 2016;118:1273–1293.
Pimenta E. Hypertension in women. Hypertens Res. 2012;35:148–152.
Zhang H, Plutzky J, Shubina M, et al. Drivers of the sex disparity in statin therapy in patients with coronary artery disease: a cohort study. PLoS One. 2016;11:e0155228.
O’Kelly AC, Michos ED, Shufelt CL, et al. Pregnancy and reproductive risk factors for cardiovascular disease in women. Circ Res. 2022;130:652–672.
Haase R, Schlattmann P, Gueret P, et al. Diagnosis of obstructive coronary artery disease using computed tomography angiography in patients with stable chest pain depending on clinical probability and in clinically important subgroups: meta-analysis of individual patient data. BMJ. 2019;365:l1945.
Truong QA, Rinehart S, Abbara S, et al. Coronary computed tomographic imaging in women: an expert consensus statement from the Society of Cardiovascular Computed Tomography. J Cardiovasc Comput Tomogr. 2018;12:451–466.
Pierre SR, Peirlinck M, Kuhl E. St Sex Matters: a comprehensive comparison of female and male hearts. Front Physiol. 2022;13:831179.
Tawakol A, Ishai A, Takx RA, et al. Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study. Lancet. 2017;389:834–845.
Fiechter M, Haider A, Bengs S, et al. Sex-dependent association between inflammation, neural stress responses, and impaired myocardial function. Eur J Nucl Med Mol Imaging. 2020;47:2010–2015.
Vaccarino V, Sullivan S, Hammadah M, et al. Mental stress-induced-myocardial ischemia in young patients with recent myocardial infarction: sex differences and mechanisms. Circulation. 2018;137:794–805.
Mehta PK, Wei J, Shufelt C, et al. Gender-Related differences in chest pain syndromes in the frontiers in CV medicine special issue: sex & Gender in CV medicine. Front Cardiovasc Med. 2021;8:744788.
Pasternak RC, Abrams J, Greenland P, et al. 34th Bethesda Conference: Task force #1--Identification of coronary heart disease risk: is there a detection gap? J Am Coll Cardiol. 2003;41:1863–1874.
Edvardsen T, Asch FM, Davidson B, et al. Non-invasive imaging in coronary syndromes: recommendations of the European Association of Cardiovascular Imaging and the American Society of Echocardiography, in collaboration with the American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Eur Heart J Cardiovasc Imaging. 2022;23:e6–e33.
Rodriguez Lozano PF, Rrapo Kaso E, Bourque JM, et al. Cardiovascular imaging for ischemic heart disease in women: time for a paradigm shift. JACC Cardiovasc Imaging. 2022;15:1488–1501.
Writing Committee Members Lawton JS, Tamis-Holland JE, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79:e21–e129.
Jespersen L, Hvelplund A, Abildstrøm SZ, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012;33:734–744.
Kenkre TS, Malhotra P, Johnson BD, et al. Ten-Year Mortality in the WISE Study (Women’s Ischemia Syndrome. Evaluation) Circ Cardiovasc Qual Outcomes. 2017;10:e003863.
Iorga A, Cunningham CM, Moazeni S, et al. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017;8:33.
Duda-Pyszny D, Trzeciak P, Gąsior M. Coronary artery disease in women. Kardiochir Torakochirurgia Pol. 2018;15:44–48.
Crea F, Battipaglia I, Andreotti F. Sex differences in mechanisms, presentation and management of ischaemic heart disease. Atherosclerosis. 2015;241:157–168.
Feuchtner GM, Cury RC, Jodocy D, et al. Differences in coronary plaque composition by noninvasive computed tomography angiography in individuals with and without obstructive coronary artery disease. Atherosclerosis. 2011;215:90–95.
Schulman-Marcus J, Hartaigh BÓ, Gransar H, et al. Sex-specific associations between coronary artery plaque extent and risk of major adverse cardiovascular events: the CONFIRM long-term registry. JACC Cardiovasc Imaging. 2016;9:364–372.
Dolor RJ, Patel MR, Melloni C, et al. Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women. Agency for Healthcare Research and Quality (US); 2012.Accessed December 7, 2022. http://www.ncbi.nlm.nih.gov/books/NBK98721/
Kharabsheh SM, Al-Sugair A, Al-Buraiki J, et al. Overview of exercise stress testing. Ann Saudi Med. 2006;26:1–6.
Bokhari S, Shahzad A, Bergmann SR. Superiority of exercise myocardial perfusion imaging compared with the exercise ECG in the diagnosis of coronary artery disease. Coron Artery Dis. 2008;19:399–404.
Shaw LJ, Mieres JH, Hendel RH, et al. Comparative effectiveness of exercise electrocardiography with or without myocardial perfusion single photon emission computed tomography in women with suspected coronary artery disease: results from the What Is the Optimal Method for Ischemia Evaluation in Women (WOMEN) trial. Circulation. 2011;124:1239–1249.
Iskandar A, Limone B, Parker MW, et al. Gender differences in the diagnostic accuracy of SPECT myocardial perfusion imaging: a bivariate meta-analysis. J Nucl Cardiol. 2013;20:53–63.
Hansen CL, Crabbe D, Rubin S. Lower diagnostic accuracy of thallium-201 SPECT myocardial perfusion imaging in women: an effect of smaller chamber size. J Am Coll Cardiol. 1996;28:1214–1219.
Metz LD, Beattie M, Hom R, et al. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol. 2007;49:227–237.
Valeti US, Miller TD, Hodge DO, et al. Exercise single-photon emission computed tomography provides effective risk stratification of elderly men and elderly women. Circulation. 2005;111:1771–1776.
Shaw LJ, Hendel RC, Cerquiera M, et al. Ethnic differences in the prognostic value of stress technetium-99m tetrofosmin gated single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol. 2005;45:1494–1504.
Parker MW, Iskandar A, Limone B, et al. Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis. Circ Cardiovasc Imaging. 2012;5:700–707.
Mc Ardle BA, Dowsley TF, deKemp RA, et al. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease?: A systematic review and meta-analysis. J Am Coll Cardiol. 2012;60:1828–1837.
Taqueti VR, Shaw LJ, Cook NR, et al. Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease. Circulation. 2017;135:566–577.
Pepine CJ, Anderson RD, Sharaf BL, et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) study. J Am Coll Cardiol. 2010;55:2825–2832.
Taqueti VR, Di Carli MF. Radionuclide myocardial perfusion imaging for the evaluation of patients with known or suspected coronary artery disease in the era of multimodality cardiovascular imaging. Prog Cardiovasc Dis. 2015;57:644–653.
Tsang JC, Min JK, Lin FY, et al. Sex comparison of diagnostic accuracy of 64-multidetector row coronary computed tomographic angiography: results from the multicenter ACCURACY trial. J Cardiovasc Comput Tomogr. 2012;6:246–251.
Penagaluri A, Higgins AY, Vavere AL, et al. Computed Tomographic Perfusion Improves Diagnostic Power of Coronary Computed Tomographic Angiography in Women: Analysis of the CORE320 Trial (Coronary Artery Evaluation Using 320-Row Multidetector Computed Tomography Angiography and Myocardial Perfusion) According to Gender. Circ Cardiovasc Imaging. 2016;9:e005189.
Meijboom WB, Weustink AC, Pugliese F, et al. Comparison of diagnostic accuracy of 64-slice computed tomography coronary angiography in women versus men with angina pectoris. Am J Cardiol. 2007;100:1532–1537.
Douglas PS, Hoffmann U, Patel MR, et al. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med. 2015;372:1291–1300.
Pagidipati NJ, Hemal K, Coles A, et al. Sex differences in functional and CT angiography testing in patients with suspected coronary artery disease. J Am Coll Cardiol. 2016;67:2607–2616.
Shaw LJ, Min JK, Nasir K, et al. Sex differences in calcified plaque and long-term cardiovascular mortality: observations from the CAC Consortium. Eur Heart J. 2018;39:3727–3735.
Villines TC, Hulten EA, Shaw LJ, et al. Prevalence and severity of coronary artery disease and adverse events among symptomatic patients with coronary artery calcification scores of zero undergoing coronary computed tomography angiography: results from the CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) registry. J Am Coll Cardiol. 2011;58:2533–2540.
Lubbers M, Dedic A, Coenen A, et al. Calcium imaging and selective computed tomography angiography in comparison to functional testing for suspected coronary artery disease: the multicentre, randomized CRESCENT trial. Eur Heart J. 2016;37:1232–1243.
Mieres JH, Udelson JE. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol. 1999;84:1454–1456.
Fleischmann KE, Hunink MG, Kuntz KM, et al. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA. 1998;280:913–920.
Kim MN, Kim SA, Kim YH, et al. Head to head comparison of stress echocardiography with exercise electrocardiography for the detection of coronary artery stenosis in women. J Cardiovasc Ultrasound. 2016;24:135–143.
Greenwood JP, Motwani M, Maredia N, et al. Comparison of cardiovascular magnetic resonance and single-photon emission computed tomography in women with suspected coronary artery disease from the Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) Trial. Circulation. 2014;129:1129–1138.
Lipinski MJ, McVey CM, Berger JS, et al. Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis. J Am Coll Cardiol. 2013;62:826–838.
Zorach B, Shaw PW, Bourque J, et al. Quantitative cardiovascular magnetic resonance perfusion imaging identifies reduced flow reserve in microvascular coronary artery disease. J Cardiovasc Magn Reson. 2018;20:14.
Knott KD, Seraphim A, Augusto JB, et al. The prognostic significance of quantitative myocardial perfusion: an artificial intelligence-based approach using perfusion mapping. Circulation. 2020;141:1282–1291.
Bucciarelli-Ducci C, Ostenfeld E, Baldassarre LA, et al. Cardiovascular disease in women: insights from magnetic resonance imaging. J Cardiovasc Magn Reson. 2020;22:71.
Dastidar AG, Baritussio A, De Garate E, et al. Prognostic role of CMR and conventional risk factors in myocardial infarction with nonobstructed coronary arteries. JACC Cardiovasc Imaging. 2019;12:1973–1982.
Reynolds HR, Maehara A, Kwong RY, et al. Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine underlying causes of myocardial infarction with nonobstructive coronary arteries in women. Circulation. 2021;143:624–640.
Gulati M, Levy PD, Mukherjee D, et al. Correction to: 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144:e455.
Gulati M, Parwani P. Myocardial blood flow reserve. JACC: Cardiovascular Imaging. 2022;15:1645–1647.
Bateman TM, Dilsizian V, Beanlands RS, et al. American society of nuclear cardiology and society of nuclear medicine and molecular imaging joint position statement on the clinical indications for myocardial perfusion PET. J Nucl Cardiol. 2016;23:1227–1231.
Taqueti VR, Dorbala S, Wolinsky D, et al. Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease—state-of-the-evidence and clinical recommendations. J Nucl Cardiol. 2017;24:1402–1426.
Murthy VL, Naya M, Foster CR, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011;124:2215–2224.
Engblom H, Xue H, Akil S, et al. Fully quantitative cardiovascular magnetic resonance myocardial perfusion ready for clinical use: a comparison between cardiovascular magnetic resonance imaging and positron emission tomography. J Cardiovasc Magn Reson. 2017;19:78.
Mygind ND, Pena A, Mide Michelsen M, et al. Myocardial first pass perfusion assessed by cardiac magnetic resonance and coronary microvascular dysfunction in women with angina and no obstructive coronary artery disease. Scand J Clin Lab Invest. 2019;79:238–246.
Sammut EC, Villa ADM, Di Giovine G, et al. Prognostic value of quantitative stress perfusion cardiac magnetic resonance. JACC Cardiovasc Imaging. 2018;11:686–694.
Morton G, Chiribiri A, Ishida M, et al. Quantification of absolute myocardial perfusion in patients with coronary artery disease. J Am Coll Cardiol. 2012;60:1546–1555.
van Dijk R, van Assen M, Vliegenthart R, et al. Diagnostic performance of semi-quantitative and quantitative stress CMR perfusion analysis: a meta-analysis. J Cardiovasc Magn Reson. 2017;19:92.
Thomson LEJ, Wei J, Agarwal M, et al. Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction: a national heart, lung, and blood institute-sponsored study from the women’s ischemia syndrome evaluation. Circ: Cardiovascular Imaging. 2015;8:e002481.
Xue H, Brown LAE, Nielles‐Vallespin S, et al. Automatic in‐line quantitative myocardial perfusion mapping: processing algorithm and implementation. Magn Reson Med. 2020;83:712–730.
Nickander J, Themudo R, Sigfridsson A, et al. Females have higher myocardial perfusion, blood volume and extracellular volume compared to males - an adenosine stress cardiovascular magnetic resonance study. Sci Rep. 2020;10:10380.
Indorkar R, Kwong RY, Romano S, et al. Global coronary flow reserve measured during stress cardiac magnetic resonance imaging is an independent predictor of adverse cardiovascular events. JACC: Cardiovascular Imaging. 2019;12:1686–1695.
Achenbach S, Fuchs F, Goncalves A, et al. Non-invasive imaging as the cornerstone of cardiovascular precision medicine. Eur Heart J Cardiovasc Imaging. 2022;23:465–475.
Kumar M, Salem K, Jeffery JJ, et al. PET Imaging of estrogen receptors using 18F-based radioligands. Methods Mol Biol. 2022;2418:129–151.
Jacene H, Liu M, Cheng SC, et al. Imaging androgen receptors in breast cancer with 18F-Fluoro-5α-Dihydrotestosterone PET: a pilot study. J Nucl Med. 2022;63:22–28.
Mikail N, Rossi A, Bengs S, et al. Imaging of heart disease in women: review and case presentation. Eur J Nucl Med Mol Imaging. 2022;50:130–159.